September 25th 2024
A continuous increase in ASCVD risk was seen with higher levels of lipoprotein(a) in the largest study to date of the relationship.
A Photo Quiz to Hone Dermatologic Skills
December 31st 2006For 2 days, a 43-year-old woman has had a slightly tender rash on her trunk andextremities. Five days earlier, the patient was given levofloxacin for an upperrespiratory tract infection; because she is prone to yeast infections while takingantibiotics, fluconazole also was prescribed. Her only other medication is an oralcontraceptive, which she has been taking for several years.
CHD Prevention and Current CHD Prevention and Current Is Lower Better?
December 31st 2006A major controversyin cardiologytoday iswhether loweringthe level oflow-density lipoprotein cholesterol(LDL-C) to substantiallybelow 100mg/dL-the current NationalCholesterol EducationProgram goal for patientswith existing coronaryheart disease1-willfurther reduce the incidenceof cardiovascularmorbidity and mortality.
Biomarkers No Substitute for Traditional Cardiovascular Risk Factors
December 20th 2006BOSTON -- Multiple biomarkers such as C-reactive protein, homocysteine, and B-type natriuretic peptide add nuance but little substance to time-honored prognostic cardiovascular risk factors, researchers here reported.
Despite Pfizer's high-profile drug failure, boosting HDL still a key heart-disease strategy
December 20th 2006Despite Pfizer's high-profile drug failure, boosting HDL still a key heart-disease strategy. Several drugs in development use various mechanisms to raise levels of "good cholesterol." Meanwhile, physicians can do plenty right now to raise patients' HDL levels.
New York City Bans Artificial Trans Fats in Restaurants
December 6th 2006NEW YORK -- The action by this city's Board of Health to ban the use of artificial trans fats in restaurants, ranging from pizzerias and delis to bakeries and upscale restaurants, could have fallout for mouths and lipid levels across the nation.
PSA Recurrence of Prostate Cancer:
December 1st 2006ABSTRACT: Prostate-specific antigen (PSA) recurrence is the most common form of advanced prostate cancer. Salvage therapies may be effective even among some high-risk men, although long-term cancer control data are limited. The natural history of PSA recurrence is long but variable. The postrecurrence PSA doubling time can identify men at high risk for progression and death. Early hormonal therapy, possibly via combined androgen blockade, may reduce the risk of progression and improve cancer-specific survival among men with high-risk recurrence. Men with low-risk recurrences likely receive minimal benefit from aggressive early hormonal therapy and may actually be harmed.
Malaria Drug Good News For Fat Mice
November 7th 2006ST. LOUIS -- What a week for fat mice! Only days after Harvard researchers squeaked with joy about the wonders of a compound in red wine, investigators here said a drug used to treat malaria can reverse the so-called metabolic syndrome in chubby rodents.
65-year-old man with nonpruritic yellowish lesions on his eyelids
October 10th 2006A 65-year-old man consults his primary care physician because of concern about nonpruritic yellowish lesions on his eyelids. He says they have been present for the past few years but have recently become more numerous.
A Call to Test for H. Pylori Before Starting NSAIDs in High Risk Patients
September 22nd 2006BIRMINGHAM, Ala. -- The American Gastroenterology Association has issued recommendations aimed at balancing the gastrointestinal and cardiovascular pluses and minuses when using nonsteroidal anti-inflammatory drugs (NSAIDs).
B Vitamin Prevents MS Disability in Mice
September 20th 2006BOSTON -- A form of niacin may be a novel treatment for chronic progressive multiple sclerosis, according to researchers here. In a mouse model of MS, nicotinamide- the amide form of niacin, or vitamin B3 - significantly prevented disability.
Marker Signals High Heart Disease Risk in Some Women
September 19th 2006BOSTON -- Women with high serum levels of lipoprotein(a) are at an increased risk for cardiovascular disease, especially if they also have high levels of LDL. But the risk marker is not likely to be useful in widespread screening for heart disease risk.